|
PMID 30777297
|
Ebola virus disease |
Malvy |
2019 |
|
PMID 28256310
|
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus |
Glynn |
2017 |
|
PMID 16002313
|
The natural history of Ebola virus in Africa |
Pourrut |
2005 |
|
PMID 32868789
|
Bats as putative Zaire ebolavirus reservoir hosts and their habitat suitability in Africa |
Koch |
2020 |
|
PMID 32117225
|
Novel Insights Into Immune Systems of Bats |
Banerjee |
2020 |
|
PMID 30150734
|
The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses |
Goldstein |
2018 |
|
PMID 28396469
|
The Ebola outbreak, 2013-2016: old lessons for new epidemics. Philos. Trans. R |
Coltart |
2017 |
|
PMID 30799252
|
Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey |
Timothy |
2019 |
|
PMID 25550396
|
Investigating the zoonotic origin of the West African Ebola epidemic |
Mari Saez |
2015 |
|
PMID 31310231
|
Bombali Virus in Mops condylurus Bats, Guinea |
Karan |
2019 |
|
PMID 23055920
|
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection |
Amman |
2012 |
|
PMID 31980636
|
Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa |
Amman |
2020 |
|
PMID 34526718
|
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks |
Keita |
2021 |
|
PMID 33893144
|
Spillover or endemic? Reconsidering the origins of Ebola virus disease outbreaks by revisiting local accounts in light of new evidence from Guinea |
Fairhead |
2021 |
|
PMID 28140390
|
A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection |
Bower |
2017 |
|
PMID 28256309
|
Asymptomatic Ebola virus infections-myth or reality? Lancet Infect |
Kuhn |
2017 |
|
PMID 21666792
|
Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus |
Macneil |
2011 |
|
PMID 33065039
|
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study |
Thom |
2021 |
|
PMID 35544108
|
Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study |
Diallo |
2021 |
|
PMID 29253164
|
Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection |
Rimoin |
2018 |
|
PMID 36536884
|
Bushmeat, wet markets, and the risks of pandemics: Exploring the nexus through systematic review of scientific disclosures |
Peros |
2021 |
|
PMID 31369554
|
Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study |
Halfmann |
2019 |
|
-
|
Understanding Social Resistance to the Ebola Response in the Forest Region of the Republic of Guinea: An Anthropological Perspective: Cambridge University Press; 7-31 p. (2016) |
Fairhead |
2016 |
|
PMID 30239838
|
Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo |
Hoff |
2019 |
|
PMID 27846221
|
Minimally Symptomatic Infection in an Ebola ‘Hotspot’: A Cross-Sectional Serosurvey |
Richardson |
2016 |
|
PMID 28396479
|
Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016. Philos. Trans. R |
Garske |
2017 |
|
PMID 31194734
In OmniVira
|
Estimating undetected Ebola spillovers. |
Glennon |
2019 |
|
PMID 33169111
In OmniVira
|
Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak. |
Goldstein |
2020 |
|
PMID 26806128
|
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection |
Flyak |
2016 |
|
PMID 30107445
|
Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors |
Bramble |
2018 |
|
PMID 27335383
|
Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses |
Natesan |
2016 |
|
PMID 25723165
|
Structural basis for Marburg virus neutralization by a cross-reactive human antibody |
Hashiguchi |
2015 |
|
PMID 28555073
|
Pathways to zoonotic spillover |
Plowright |
2017 |
|
PMID 31522809
|
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
Noad |
2019 |
|
-
|
TREE COVER LOSS IN MACENTA, NZÉRÉKORÉ, GUINEA 2023 [Available from: |
watch Gf |
2023 |
|
PMID 26715676
|
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection |
Dowall |
2016 |
|
PMID 35203111
|
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers |
Laing |
2022 |
|
-
|
A Luminex-based multiplex assay for the simultaneous detection of glycoprotein specific antibodies to ebolaviruses, marburgviruses, and henipaviruses. Int |
Laing |
2016 |
|
PMID 19252850
|
Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery |
Chan |
2009 |
|
PMID 37610572
|
Recombinant Soluble Henipavirus Glycoprotein Preparation |
Yan |
2023 |